Report-Global-Survey-09 WHO
Report-Global-Survey-09 WHO
3. Summary 37
3.1 Summary of Progress 37
3.2 Summaries by Risk Factor and Disease Groups 37
4. Qualitative Results 40
4.1 Ranking of NCD Prevention and Control
as a Priority for Action 40
4.2 Barriers and Constraints 42
4.3 Surveillance of Chronic Diseases Prevention and Control 43
4.4 Priority Areas of WHO Technical Support FOREWORD
for Chronic Disease Prevention and Control 44
References 48
Annex 2 - Explanation of Terms 62 The World Health Assembly (WHA) endorsed the Global Strategy for
Prevention and Control of Noncommunicable Diseases (NCDs) in May 2000. In
Annex 3 - Key Informant Questions 66 2001 and as a follow-up to the Global Strategy, WHO conducted a survey to
assess its Member States’ capacity to respond to NCDs, and to learn how best
Annex 4 - List of WHO Member States Responding to assist them. Since then, WHO has prompted actions targeted at NCDs, which
to the Global Survey 69 culminated in a series of vital WHO documents. The World Health Report 2002,
Reducing Risk, Promoting Healthy Life, raised awareness of risk factors. In 2003
and 2004, the WHA endorsed, respectively, the Framework Convention on Tobacco
Control (FCTC) and the WHO Global Strategy on Diet, Physical Activity and
Health (DPAS). In October 2005, the WHO Global Report on “Preventing chronic
diseases: a vital investment’’ was launched. This report makes the case for urgent
action to halt and turn back the growing threat of chronic diseases. WHO has at
all times been actively supporting partnerships and networking among Member
States committed to NCD prevention and control.
While the achievements made at country and global levels since 2000-2001
are encouraging, the NCD burden is predicted to grow unless more decisive
action is taken. In this context, the Department of Chronic Diseases and Health
Promotion at WHO Headquarters initiated a new wave of surveys whose
instruments included quantitative and qualitative components. Thanks to the
cooperation of the regional offices, all WHO regions were surveyed in 2005-2006
with the exception of the Western Pacific Region (WPR), where the Regional
Office had conducted a similar survey in 2004. A quantitative questionnaire
was mailed or emailed to Member States and responses were checked by WHO
regional offices. Later, in all WHO regions except the European Region (EUR),
key informant interviews were carried out aimed at collecting relevant qualitative
6 7
Dr Catherine Le Galès-Camus This survey received strong support and cooperation from key persons in
Assistant Director-General the Member States and our colleagues at country offices, regional offices and
Noncommunicable Diseases and Mental Health Headquarters. Without their wholehearted assistance, it would not have been
possible to implement the survey.
Actively involved in this project during the planning and implementation
phases were our colleagues in the six WHO regional offices: Drs Antonio Filipe
Jr and Sidi Allel Louazani (AFRO), Lucimar Coser Cannon (AMRO), Oussama
Khatib (EMRO), Jill Farrington and Aushra Shatchkute (EURO), Jerzy Leowski
(SEARO), and Gauden Galea (WPRO). Their spirit of team work and partnership
is highly appreciated. Thanks should also be extended to all WHO country
counterparts who were involved in both the questionnaire filling exercise and the
key informant interviews.
Drs Robert Beaglehole and Colin Tukuitonga provided extensive comments
and inputs to the questionnaires and to subsequent drafts of the report prepared
by Drs Ruitai Shao and Bao Liu. Ms Barbara Legowski assisted in the finalization
of the report. Dr Juan Zhang provided assistance in interviewing key informants,
and Dr Lei Huang contributed to the drafts of the report. The support given by
colleagues in the Departments of Chronic Diseases and Health Promotion, Mental
Health and Substance Abuse, Nutrition for Health and Development, and Tobacco
Free Initiatives is gratefully acknowledged. Invaluable secretarial assistance was
provided throughout by Ms Hilda Muriuki. Ms Rebecca Harding was responsible
for the cover and lay-out design.
Finally, this survey also benefited greatly from the contributions of the WHO
collaborating centre on Chronic Diseases Policy at the Public Health Agency of
Canada. Special thanks are extended to Dr Sylvie Stachenko.
8 9
ABBREVIATIONS
EXECUTIVE SUMMARY
While achievements made at country and global levels since 2000-2001 are
encouraging, the NCD burden is predicted to grow unless much more decisive
action is taken. It is in this context that the Department of Chronic Diseases and
Health Promotion at WHO Headquarters has conducted a new survey with the
following objectives: to assess the capacity of national chronic disease prevention
and control in development, implementation of national policy, and action plan and
programmes; to promote sharing of information, experiences and best practices;
to identify constraints and needs of technical assistance; and to assist national
strategy and policy formulation, development, implementation and evaluation.
This report contains the results of these inquiries.
The survey had quantitative and qualitative components: a self-administered
questionnaire and key informant interviews. Five WHO regions were surveyed
in 2005-2006; in the Western Pacific Region (WPR), a questionnaire similar
to that administered in the other regions, was already completed in 2004 and
was reinforced by interviews in 2006. The global questionnaire had an overall
response rate of 69%, and was completed by 133 countries. A sub-set of 118
countries responded to both the first and later surveys, permitting an assessment
of progress. Progress is also reported for a group of 97 countries; these do not
include WPR because some questions were not in the WPR survey. In total, 26
key informants were interviewed from all regions except the European Region
(EUR).
In the group of 97 countries that excludes WPR, progress since 2000-2001 is
evident for a number of indicators: more countries have NCD units or departments
in their ministries of health, more have budgets specific to NCD policies, and more
have action plans for tobacco control, diabetes, heart disease and cancer. Across all
12 13
Regions, national policies and programmes are most common for tobacco control, are less common for risk factors than for individual diseases, and they now exist
followed by nutrition/diet, cancer and diabetes. Policies for other risk factors and most often for diet (in 38% of countries) and smoking cessation (in 33%).
diseases are in place in between 20% and 35% of countries, depending on the With regard to the sources of financing for NCD prevention and control,
region. But despite the progress in policy development, key informants cautioned about 32% of countries on average identified international financial aid. The
that simply having a policy may suggest that the issue has high priority when, in proportion in EUR was lowest (16%). Very few countries reported taxation on
reality, implementation is often constrained by lack of financial resources. tobacco, alcohol and unhealthy food as sources of funding. As for taxes on alcohol,
As regards the FCTC and DPAS, 65% of respondents, excluding WPR, are the countries in EUR have the highest proportions (18%); while the countries in
contracting parties to the FCTC and 31% report a corresponding comprehensive AMR have the highest proportions of taxation on cigarettes (26%).
action plan. In the same group of countries, only 29 reported implementing DPAS Progress is apparent in the countries that responded to both surveys. However,
while 19 replied that they planned to do so. there are a number of key areas for action that are similar to those reported in
Among all respondents, 85% have now introduced tobacco control 2000-2001 and which re-emerge as priorities for WHO technical support to
legislation, an increase of 23% since 2000-2001. About 50% have no legislation Member States. These areas include advocacy, continuing assistance to countries
for alcohol control. The proportion of countries with food and nutrition legislation to strengthen surveillance systems, capacity building for the development,
has increased since 2000-2001, but it is unclear whether this concerns NCD implementation and evaluation of policies, action plans and programmes, and the
prevention and control, as opposed to food safety. creation of more channels, platforms and other occasions for sharing information
with best practice at different levels. In addition, regular global reviews should be
Compared to 2000-2001, more countries now include NCD information
encouraged in order to help WHO to measure the progress as well as to identify
in their annual health reporting systems but still only a small proportion
the Member States’ needs for technical support.
(26%) include risk factor data in these systems. More countries take account
of hypertension, diabetes and cancer in their surveillance systems but,
again, risk factors are less often included. However, between 2000-2005, all
responding countries carried out studies or surveys on risk factors, most often
for tobacco use (82%), and between 60% and 70% for overweight and obesity,
hypertension, diabetes, diet, physical activity and alcohol use. The frequency
of these studies is not known. Training for surveillance remains a barrier
according to key informants, and the challenge remains as to how to convert
the available data into strategic information that can influence policies and
mobilize resources for prevention.
On average, half of the 133 countries responding reported national targets
for NCD prevention and control. About 60% of them said that ministries of health
were involved in setting these targets, while some 40% of countries reported
the additional involvement of WHO, disease-specific associations, medical/
health professionals and academic institutions. Private citizens, community
organizations, specific population groups and consumer organizations played a
role in less than one-quarter of countries.
Across regions except WPR, almost half of the countries reported
demonstration programmes that apply an integrated approach to NCD prevention
and control, while 37% have such programmes specific to certain risk factors. In
about 35% of countries, the projects target children aged under 15 and adults aged
25-64 years. Most common are projects in schools.
Countries have made progress since 2000-2001 in making available and using
national protocols for dealing with hypertension, diabetes and cancer. Protocols
14 15
INTRODUCTION
The Global Strategy and Resolution WHA 53.14 requested WHO to provide
technical support and appropriate guidance to Member States in assessing their
needs, developing effective programmes and adapting their health systems
to respond to the NCD epidemic. Following the adoption of the Resolution
WHO conducted its first Global Survey on Assessment of National Capacity
for Noncommunicable Disease Prevention and Control: The Report of a Global
Survey (2001). The Survey was aimed at: assessing existing country capacity
in health policy, programmes and infrastructure to prevent, control and treat
NCD; identifying constraints and needs among Member States; setting priorities
for WHO technical support to Member States; and assisting them in planning,
implementing and evaluating their responses.
Since 2000, WHO has invoked various other instruments to prompt action
on NCD prevention and control. The 2002 World Health Report Reducing Risk,
Promoting Healthy Life focused on risk factors; in 2003, the World Health Assembly
(WHA) endorsed the Framework Convention on Tobacco Control (FCTC); and in
2004 WHO released the Global Strategy on Diet, Physical activity and Health
(DPAS). WHO has also supported partnerships and networking among Member
States by convening four global forums on NCD prevention and control since
2001, encouraging the development of policy observatories, and supporting new
and existing networks of national and demonstration level programmes aimed at
preventing and controlling NCDs.
Despite global successes since 2000 such as the FCTC and individual country
achievements, the risk factors and the NCD threat have been neglected in many
parts of the world, and the NCD burden is growing. Out of a projected total of
58 million deaths from all causes in 2005, WHO estimates that 35 million were
16 17
due to NCDs. By 2015, unless there is significant decisive action, the estimate For the qualitative component, with the exception of EMR and EUR,
will increase to 41 million deaths. Low and middle income countries, where WHO HQ interviewers interacted with key informants using a semi-structured
80% of deaths are occurring, suffer the largest burden. Human and economic questionnaire, similar to that used in 2000-2001, and prepared notes. (See Annex
development on a global scale are threatened, as affected individuals lose quality 3 for the qualitative questionnaire.) The regional advisors for NCD recommended
of life, workforces are reduced by premature deaths, and economic losses are key informants to the WHO HQ research team on the basis of the informants’
experienced from household to national levels. knowledge of NCD situations in their respective countries, their English language
capacity and their technical background. Interviews were not conducted in EUR.
In 2005-2006, in order to assess progress in NCD prevention and control
Information was collected for 26 countries, from low income, lower middle income
capacity since 2000, and to re-examine the nature of WHO technical assistance
and higher middle income groupings. Most often, there was one key informant
that is most needed, the Department of Chronic Diseases and Health Promotion at
per country, interviewed during April, May, June or July of 2006. For the most
WHO Headquarters conducted a new survey, also with quantitative and qualitative
part, interviews occurred over the telephone.
components. With the cooperation of the regional offices, all WHO regions were
surveyed in 2005-2006 with the exception of WPR, where the regional office had The data and information collected were not validated by independent
conducted a similar survey in 2004. sources. Depending on the number of key informants interviewed in a region,
it may be possible to generalize their information to the region. But overall, the
The new survey had six core topics repeated from the 2000-2001 survey. interview information cannot be generalized across regions.
They covered: national focal points, units/departments and institutes; national
acts, laws, legislation, decrees; national policies, strategies, action plans and 1.2 Data Imputation and Cleaning
programmes; national health reporting systems, surveys and surveillance; Missing data from the quantitative survey were inferred after additional
protocols, guidelines and standards; and financial resources. Three topics were consultation with focal points at the WHO regional offices and with Member
new: demonstration programmes; national targets; and DPAS and FCTC. The States. In order for the final database to be sufficiently complete and accurate for
sections common to both surveys deal for the most part with NCD prevention and analysis, the WHO HQ team thoroughly cleaned all the variables in the dataset in
control. Treatment capacity was not assessed in the new survey to the extent that addition to the built-in check procedure of the data entry program.
it was in 2000-2001.
1.3 Data Analysis
This report presents the quantitative and qualitative findings from the new
survey. The progress made in the period between the two surveys is estimated Descriptive analysis is generally used for this first stage data analysis. STATA
for topics covered in both surveys, and the development of new capacities is 9 software was used for writing all the statistical programs for analysis.
reported.
2. QUANTITATIVE RESULTS
Table 1.1 Response rates to the global survey, by WHO Region control institute; MOH unit or department refers to an administrative agency in
MOH for disease prevention and control or for prevention and control of chronic
Region Respondent Non-Respondent Total Response diseases; a national institute refers to a national public health institute or a
States States Rate (%) specialized institute for chronic disease prevention and control.
AFR 26 20 46 57
Findings
AMR 27 8 35 77
Table 2-1 showed that, among the 112 respondent countries (omitting WPR),
EMR 15 6 21 71
although 86% had focal points for chronic diseases prevention and control, only
EUR 38 14 52 73 about half of the states (49%) reported having national institutes for chronic
SEAR 6 5 11 55 disease prevention and control. Most responding states (79%) reported having a
WPR a
21 6 27 78 unit (or department) in the Ministry of Health for NCD and, as shown in Table 2-2
for all the five regions, in 2005~2006 this percentage was at least 24% higher than
Total 133 59 192 69
that in 2000~2001.
a
WPR data were collected in 2004.
2.2 Focal Point, Unit / Department and Institute 2.3 Act, Law, Legislation and Ministerial Decree
National focal point, unit/department and institute National act, law, legislation and ministerial decree
for chronic diseases prevention and control for chronic diseases prevention and control
Table 2-1 and Table 2-2 report, by WHO region, on the availability of a national Table 3-1 and Table 3-2 report, by WHO region, on the existence of a national
focal point, national unit (or department) in the Ministry of Health (MOH), and a act, law, legislation and ministerial decree for NCD prevention and control. This
national institute for chronic disease prevention and control. A national focal point refers to nationally approved legal documents targeting prevention and control of
refers to the person responsible for prevention and control of chronic diseases in chronic diseases and risk factors; or to prevention and control of chronic diseases
MOH, in a national public health institute or in a chronic disease prevention and or related risk factors as part of the relevant legislation.
20 21
Table 2-2 Percentage of countries establishing an MOH unit (or department) prevention and control of chronic diseases. A national policy for chronic disease
for chronic disease prevention and control prevention and control refers to a written document endorsed, in collaboration
with related sectors, by the country’s Ministry of Health, which includes a set
Region 2000~2001 2005~2006 of statements and decisions defining goals, priorities and main directions for
AFR 63 83 attaining these goals. The policy document may also include a strategy containing
AMR 63 83
main lines of action that are adopted to give effect to the policy.
EMR 62 92
EUR 60 83 Table 3-2 Percentage of countries having legislation for tobacco control,
SEAR 33 67 and food and nutrition in 2000~2001 and 2005~2006, by WHO Region
WPR NA NA
Tobacco control Food and nutrition
Total 60 84
Region 2000~2001 2005~2006 2000~2001 2005~2006
NA, no data available.
AFR 25 67 50 75
Findings AMR 58 71 67 83
EMR 69 92 69 85
Table 3-1 showed that out of the 133 respondent countries, 85%, 83%, 52%
and 23% reported having legislative instruments dealing respectively with tobacco EUR 80 100 80 100
control, food and nutrition, alcohol control and physical activity legislation related SEAR 67 100 83 100
to chronic disease prevention and control. In addition, the results in Table 3-2 WPRa 71 86 76 76
showed that the last five years saw 23% and 16% increases in the proportion
Total 61 84 70 86
of countries having legislation for tobacco control and for food and nutrition.
By contrast, the percentages of countries having legislation for alcohol control a
WPR data were collected in 2004.
and physical activity were on average much lower, with only around 25% of
respondent states having legislation for physical activity (Table 3-1). A national integrated programme refers to the country’s core public health
principles incorporated into a country action plan for chronic diseases prevention
Table 3-1 Percentage of countries having national act, law, legislation, ministerial decree and control through a concerted approach addressing the multidisciplinary range of
for chronic diseases prevention and control, by WHO Region, 2005~2006 issues within a prevention and health promotion framework across the broad range
of chronic diseases. A national integrated programme generally targets all major
Risk factors Total AFR AMR EMR EUR SEAR WPRa common risk factors common to main chronic diseases, and integrates primary,
Tobacco control 85 69 74 93 97 100 86 secondary and tertiary prevention, health promotion and disease prevention. It
Food and nutrition 83 73 82 80 92 100 76
may include programmes across sectors and disciplines and, rather than relying
on a disjointed set of small-scale projects, it will seek to harmonize and integrate
Alcohol control 52 35 59 60 74 33 24
actions within existing public health systems by incorporating contemporary
Physical activity 23 12 19 27 34 50 14
evidence-based concepts.
a
WPR data were collected in 2004.
Findings
Table 4-1 showed that the percentages of countries having a national health
2.4 Policy, Strategy, Action Plan, Programme policy and a strategy relevant to chronic disease prevention and control were
Table 4-1 and Table 4-2 report on the existence, by WHO region, of a national respectively 63% and 54% (except for WPR), while 64% of countries reported
policy, strategy and integrated programme for NCD prevention and control. A having a national integrated programme in all regions. As shown in Table 4-2,
national strategy means a long-term plan of action designed to achieve the goal of for the comparable 97 countries between 2000~2001 and 2005~2006, there was
22 23
a 28% increase in the percentage of countries having a national policy relevant A national programme refers to a set of comprehensive goals and objectives
to chronic diseases prevention and control. The Table also showed that, when within the framework of national chronic disease prevention and control, which
compared with AMR, EMR and EUR, for AFR there was a persisting low rate of translate into programme goals and objectives that are consistent with the chosen
issuance of national policy relevant to chronic diseases prevention and control, intervention strategies; the programme also develops from these a blueprint of
while SEAR significantly improved on its shortfall over the past five years. how the intervention activities will operate and how to evaluate the results.
Findings
Table 4-1 Percentage of countries having national policy, strategy, and integrated programme Among the respondent countries, generally, the proportions of countries
relevant to chronic diseases prevention and control, by WHO Region, 2005~2006 having specific risk factor related national health policy (action plan, programme)
for tobacco control and nutrition/diet were in general higher than those of countries
Total AFR AMR EMR EUR SEAR WPRa having a specific national policy directly targeting chronic disease. But this is
National policy 63 39 70 67 74 50 NA not the case for risk factors like physical activity and alcohol control (Table 5,
Table 6-1, Table 7).
National strategy 54 31 63 53 63 50 NA
National integrated 64 39 63 67 74 50 76
Table 6-2 showed that, although the current percentages of countries having
programmes a specific national action plan for tobacco control, diabetes, heart diseases and
cancer were consistently much higher than those reported in the 2000~2001
NA, no data available.
a
WPR data were collected in 2004.
survey, the corresponding percentages for AFR in both surveys were much lower
than for the other four regions. And when compared with the other regions, AFR
achieved much less progress in these action plans except for tobacco control
Table 4-2 Percentage of countries having national policy relevant to chronic diseases and cancer. For instance, in AFR the percentage having a specific national heart
prevention and control in 2000~2001 and 2005~2006, by WHO Region disease action plan remained the same over the last five years, while AMR, EMR,
EUR and SEAR increased by 17%, 15%, 13% and 17%, respectively.
Region 2000~2001 2005~2006
AFR 17 46
Table 5 Percentage of countries having a specific national policy for chronic diseases
AMR 42 75
prevention and control, by WHO Region, 2005~2006
EMR 69 77
EUR 57 83 Risk factors & Diseases Total AFR AMR EMR EUR SEAR WPRa
SEAR 17 67 Tobacco control 56 39 48 73 74 67 38
WPR NA NA Nutritional/diet 50 46 56 33 63 67 33
Total 42 70 Physical activity 29 12 26 33 50 33 10
NA, no data available.
Alcohol control 28 12 26 13 50 33 19
Hypertension 30 23 37 47 40 NA 10
Diabetes 41 27 44 60 53 NA 29
Table 5, Table 6-1, Table 6-2 and Table 7 report on the existence of a national Heart diseases 34 8 33 47 53 NA NA
action plan and a programme for NCD prevention and control by WHO region.
Stroke 24 8 22 13 45 NA NA
A national action plan is a scheme, prepared according to policy and strategic
directions and with defined activities, to generate a set of products/targets in order Cancer 41 23 41 60 61 17 24
to achieve the desired goals. The action plan should identify who does what (type Chronic respiratory disease 20 4 22 33 34 NA 5
of activities and people responsible for implementation), when (time frame), how Other chronic disease 24 15 26 20 26 50 NA
and for how much (resource). It should ideally have an inherent mechanism for NA, no data available.
monitoring and evaluation. a
WPR data were collected in 200.
24 25
Table 6-1 Percentage of countries having a specific national action planfor chronic prevention and control (or for risk factors such as tobacco use, unhealthy diet
diseases prevention and control, by WHO Region, 2005~2006 and physical inactivity, and health determinants such as environment, lifestyles,
socio-economic levels etc).
Risk factors & Diseases Total AFR AMR EMR EUR SEAR WPR
Tobacco control 66 39 63 80 76 100 NA Table 7 Percentage of countries having specific national programmes for chronic diseases
Nutritional/diet 48 35 52 33 61 50 NA prevention and control, by WHO Region, 2005~2006
Physical activity 32 12 37 27 42 50 NA
Risk factors & Diseases Total AFR AMR EMR EUR SEAR WPRa
Alcohol control 30 19 22 13 47 33 NA
Tobacco control 54 31 41 67 66 100 57
Hypertension 35 19 48 47 32 33 NA
Nutritional/diet 50 42 56 47 53 33 57
Diabetes 54 27 63 60 61 67 NA
Physical activity 32 8 22 20 45 33 57
Heart diseases 46 12 48 53 61 50 NA Alcohol control 32 12 30 7 45 33 52
Stroke 20 4 26 13 26 33 NA Hypertension 42 23 52 40 42 33 57
Cancer 60 35 59 67 68 100 NA Diabetes 48 23 59 60 53 17 57
Chronic respiratory disease 18 4 15 33 24 17 NA Heart diseases 38 15 33 53 53 33 NA
Other chronic disease 24 27 26 27 21 17 NA Stroke 25 12 26 13 37 33 NA
NA, no data available. Cancer 47 19 48 60 61 33 48
Chronic respiratory disease 21 8 26 27 26 0 NA
Table 6-2 Percentage of countries having a specific national action plan for tobacco control, Other chronic disease 21 19 19 7 26 33 NA
diabetes, heart diseases, and cancer in 2000~2001 and 2005~2006, by WHO Region
NA, no data available.
a
WPR data were collected in 2004.
Tobacco control Diabetes Heart disease Cancer
2000~ 2005~ 2000~ 2005~ 2000~ 2005~ 2000~ 2005~
Findings
Region 2001 2006 2001 2006 2001 2006 2001 2006
Half of the 133 respondent countries reported having national targets for
AFR 17 38 17 25 13 13 21 33
chronic disease prevention and control, but the percentages varied widely from
AMR 29 63 46 63 29 46 50 58 region to region.
EMR 54 85 46 69 54 69 54 77 As shown in Table 8-2, among the respondent states, the proportion of
EUR 37 77 53 67 57 70 60 77 countries having sectors/organizations involved in national target-setting ranged
SEAR 67 100 50 67 33 50 83 100 widely from the reported 19% for the involvement of “other ministries” to the
highest percentage of 62% for the Ministry of Health. The percentage of countries
WPR NA NA NA NA NA NA NA NA
reporting the Ministry of Finance’s involvement in national target-setting varied
Total 34 66 41 56 37 49 49 63 from 5% in WPR to 32% and 33% in EUR and EMR.
NA, no data available.
2.6 Implementation of FCTC and DPAS
Table 9 reports on the status of FCTC and DPAS implementation. FCTC
2.5 National Target
refers to the national action plan or work plan for implementing the Framework
Table 8-1 and Table 8-2 report on the availability of national targets Convention on Tobacco Control (FCTC), adopted by WHA 56 in May 2003.
for NCD prevention and control. A national target refers to the setting of DPAS refers to the Global Strategy on Diet, Physical Activity and Health (DPAS),
quantitative output, impact, outcomes or health indicators for chronic diseases endorsed by WHA 57 in May 2004.
26 27
Table 8-1 Percentage of countries having national targets for chronic disease prevention Table 8-2 Organizations involved in setting a national target for chronic diseases
and control, by WHO Region, 2005~2006 prevention and control (percentages), by WHO Region, 2005~2006
Region National targets Organizations Total AFR AMR EMR EUR SEAR WPRa
AFR 23 Ministry of Health 62 42 56 80 79 50 52
AMR 48 Ministry of Education 31 23 26 47 50 33 0
EMR 60 Ministry of Finance 21 15 19 33 32 17 5
EUR 71 Other Ministries 19 15 11 20 29 33 10
SEAR 33 Subnational government 20 4 15 13 34 33 NA
WPR a
52 World Health Organization 42 39 41 67 50 50 14
Total 51 National NGO 37 27 26 40 50 33 NA
a
WPR data were collected in 2004.
Citizen or community 24 19 22 13 34 17 NA
representatives
Associations for specific 21 19 19 20 32 33 5
Findings population groups
Among the 112 respondent countries in AFR, AMR, EMR, EUR and SEAR, Consumer Organizations 16 15 7 7 32 17 5
65% became contracting parties to the WHO’s FCTC, and 31% already have Medical/Health 39 19 48 20 58 50 29
implemented an action plan for FCTC. As regards DPAS, 26% of 112 countries Professional Associations
had implemented DPAS, 17% had plans to do so, and 27% had established a Disease-specific 41 27 44 47 58 33 24
mechanism for discussion /interaction between national authorities and private Associations
sector interests related to DPAS. Currently no country has implemented DPAS International Nongovern- 17 15 7 20 26 17 10
in the EMR’s 15 respondent countries, but three reported having plans to do mental Organizations
so. Table 9 also showed that, out of 112 respondent countries, slightly over
Other Bilateral/Multilateral 13 8 15 13 18 33 0
one quarter had established a mechanism for discussion/interaction between Organizations
national authorities and the private sector.
Academic institutions 39 19 41 27 58 33 NA
Table 10-1, Table 10-2, Table 11, Table 12-1 and Table 12-2 report on the NA, no data available.
a
WPR data were collected in 2004.
availability of a national health reporting system, survey and surveillance in
respect of NCD and related risk factors. A health reporting system includes
annual health reports of the MOH which contain data on national capacity, Findings
human resources, demographic aspects, health expenditure and health Table 10-1 showed that the proportion of countries having an established
indicators. Morbidity information may include incidence or prevalence data health information system covering chronic diseases and major risk factors
from disease registries, hospital admissions or discharge data. A national ranged from 60% in EMR to 84% in EUR and 100% in SEAR. And out of
survey (with either fixed or unfixed time intervals) will examine the main 112 countries from AFR, AMR, EMR, EUR and SEAR, around 93% had
chronic diseases, or the major risk factors common to chronic diseases. included chronic diseases in the annual health report system. Regarding the
National surveillance refers to information on risk factors, chronic diseases data included in the annual health report system, 26% reported having full
and their determinants, used to permit which is a continuous analysis, coverage across risk factors, cause-specific mortality and morbidity. This
interpretation and feed-back of systematically collected data using a survey Table also showed that approximately 68% among 133 respondent countries
or regular registration. had a routine or regular surveillance system for chronic diseases in all
28 29
regions. And although WPR enjoyed the highest rate (86%) for establishing Table 10-1 Health information system covering chronic diseases
a routine chronic disease surveillance system, fewer than half of countries in and major risk factors, by WHO Region, 2005~2006
AFR did so.
Channels of collecting Total AFR AMR EMR EUR SEAR WPRa
information on risk factors
and chronic diseases
Table 9 Percentage of countries implementing FCTC and DPAS,
by WHO Region, 2005~2006 Health information system 77 73 74 60 84 100 NA
covering chronic diseases
and major risk factors
Total AFR AMR EMR EUR SEAR WPR
Inclusion of chronic 93 100 96 73 92 100 NA
Contracting party to the WHO 65 65 52 80 66 83 NA diseases in the annual
FCTC health report system
Implementation action plan 31 27 30 47 24 67 NA Data included in the annual
of FCTC health report system
Implementation of DPAS 26 8 26 0 45 50 NA – Cause-specific mortality 12 8 22 27 3 0 NA
Plans for the implementation 17 15 19 20 13 33 NA – Risk factors/Cause- 26 8 22 13 45 33 NA
of DPAS specific mortality/
morbidity
Mechanism for discussion/ 27 8 30 27 34 50 NA
– Cause-specific mortality/ 35 46 44 13 32 17 NA
interaction between national
morbidity
authorities and private
sector interests related to Routine or regular 68 46 67 53 76 83 86
the DPAS surveillance system
Table 10-2 showed the progress made in including chronic diseases in the Table 10-2 Percentage of countries having included chronic diseases in annual health
annual health reporting system and in establishing a routine surveillance system reporting system and surveillance system in 2000~2001 and 2005~2006, by WHO Region
for chronic disease. For the best comparable 97 countries of the two surveys
conducted in 2000~2001 and in 2005~2006 (except WPR), in general a 14% Region Inclusion of chronic diseases Routine surveillance system
increase was found for the inclusion of chronic diseases in the annual health in the annual health for chronic disease
reporting system. As regards data included in the surveillance system, among reporting system
118 countries there was a 12% increase (from 60% in 2000~2001 to 72% in 2000~2001 2005~2006 2000~2001 2005~2006
2005~2006) in countries reported to have included risk factors, cause-specific
AFR 96 100 29 50
mortality and morbidity.
AMR 75 96 54 67
Table 11 showed that during the period 2000-2005, among 112 respondent EMR 46 77 54 62
countries from AFR, AMR, EMR, EUR and SEAR, the proportion of countries EUR 93 97 77 87
having conducted national/provincial surveys or studies on such risk factors as
SEAR 67 100 67 83
tobacco use, unhealthy diet, physical inactivity and alcohol consumption stood at
WPRa NA NA 81 86
82%, 63%, 62% and 61% respectively. The percentage of countries reported as
having national/provincial studies/surveys covering risk factors and diseases varied Total 81 95 60 72
widely from 29% for chronic respiratory diseases to 82% for tobacco control. a
WPR data were collected in 2004.
30 31
Table 11 Percentage of countries having national/provincial studies/surveys during 2000- source of public and professional inspiration. Large or national programmes based
2005, by WHO Region on the experience of the demonstration areas can then be launched.
Risk factors & diseases Total AFR AMR EMR EUR SEAR WPR
Table 12-1 The coverage of the chronic disease surveillance system,
Tobacco use 82 73 82 80 87 100 NA by WHO Region, 2005~2006
Unhealthy diet 63 35 67 47 84 83 NA
Physical activity 62 31 63 53 82 83 NA Risk factors & Diseases Total AFR AMR EMR EUR SEAR WPRa
Alcohol consumption 61 35 70 20 84 83 NA Tobacco use 41 27 22 40 50 83 52
Hypertension 66 50 67 67 74 83 NA Unhealthy diet 36 19 22 40 47 67 43
Diabetes 66 42 74 73 71 83 NA Physical activity 35 15 26 47 40 67 43
Overweight and obesity 68 42 74 60 82 83 NA Alcohol consumption 34 23 22 7 50 83 38
Raised blood glucose 51 35 59 60 50 67 NA Diabetes (Elevated blood 59 50 59 47 61 50 81
Raised blood pressure 57 35 63 60 63 83 NA glucose)
Dyslipidaemia 42 23 48 60 42 50 NA Hypertension (Elevated blood 58 50 59 53 50 100 71
pressure)
Heart diseases 39 12 52 33 53 33 NA
Overweight and obesity 38 23 33 40 42 67 48
Stroke 33 8 44 20 47 33 NA
(Body Mass Index)
Cancer 46 19 48 47 63 50 NA
Dyslipidaemia (Cholesterol) 26 8 26 33 29 33 33
Chronic respiratory diseases 29 12 26 27 45 17 NA Heart diseases 43 35 41 20 58 50 NA
NA, no data available. Stroke 35 31 33 13 45 50 NA
Cancer 64 50 59 40 76 67 76
Table 12-1 indicated the coverage of the chronic disease surveillance system. Chronic respiratory diseases 33 27 33 20 45 17 NA
Out of 133 respondent countries, less than two-fifths covered the major risk factors
NA, no data available.
such as tobacco use, unhealthy diet, physical activity and alcohol consumption. The a
WPR data were collected in 2004.
results showed that the proportion of countries covering diabetes, hypertension,
heart diseases and cancer in their chronic disease surveillance system was higher
Table 12-2 The coverage of the chronic disease surveillance system
than those which included risk factors such as tobacco control, unhealthy diet,
in 2000~2001 and 2005~2006, by WHO Region
physical inactivity and alcohol consumption. Table 12-2 indicated that the last
five years saw 24%, 20% and 15% increases respectively in the proportion of Hypertension Diabetes Cancer
countries reported as covering hypertension, diabetes and cancer in their chronic
disease surveillance system. Region 2000~2001 2005~2006 2000~2001 2005~2006 2000~2001 2005~2006
AFR 25 54 25 54 29 54
2.8 National Community-based Demonstration Programmes AMR 42 58 42 58 42 58
Table 13, Table 14 and Table 15 report on the existence of national EMR 46 62 46 54 46 54
community-based demonstration programmes and their target population and EUR 27 53 47 67 70 87
settings. A national community-based demonstration programme is one which SEAR 50 100 33 50 50 67
addresses issues relevant to chronic disease prevention and major risk factors; WPR a
52 71 62 81 71 76
applies existing knowledge to put into practice effective prevention at community
level; examines different methods of disease prevention and health promotion; Total 37 61 43 63 53 68
evaluates their feasibility; and validates their effect to show how they can be a a
WPR data were collected in 2004.
32 33
Table 18 Percentage of countries having specific/dedicated budgets for the following 3. SUMMARY
chronic diseases components, by WHO Region, 2005~2006
3.1 Summary of Progress
Risk factors and diseases Total AFR AMR EMR EUR SEAR WPRa
Progress is apparent in the group of 118 countries that responded to both
Tobacco use 50 31 41 53 55 50 71 surveys. The proportion with a national act, law, legislation or ministerial decree
Nutrition/diet 49 50 48 27 55 33 57 for tobacco control increased from 61% to 84%, varying from 67% in the
Physical activity 32 15 37 13 37 17 57 African Region to 100% in the European and South-East Asian regions. The
proportion with a national act, law, legislation or ministerial decree for food
Alcohol consumption 32 23 30 7 45 0 48
and nutrition related to chronic diseases prevention and control increased from
Obesity 32 12 37 13 37 17 57 70% to 86%. The existence of budgets specific to NCD increased from 39% of
Hypertension 45 31 48 47 42 17 71 countries to 68%. In a group of 97 countries that excludes WPR, the proportion
Diabetes 53 35 52 60 55 33 71 with a national policy for chronic diseases prevention and control rose from 42%
to 70% between the two surveys, varying from 46% in the Africa Region to 83%
Heart diseases 41 23 44 40 53 33 NA
in the European Region. The proportion with an NCD unit or department in the
Stroke 30 23 41 13 32 33 NA Ministry of Health increased from 60% to 84%. In 2005, 64% of all 133 countries
Cancer 54 31 52 53 68 50 62 reported having a national integrated programme for prevention and control of
Chronic respiratory 26 15 33 33 26 17 NA
chronic diseases.
diseases
3.2 Summaries by Risk Factor and Disease Groups
NA, no data available.
a
WPR data were collected in 2004. Below, findings are organized by risk factor and disease groups, summarizing
data derived from across the tables in the previous section.
Table 19 Percentage of countries having the following financial sources for chronic
diseases prevention and control, by WHO Region, 2005~2006
3.2.1 Tobacco
Among all 133 respondents, 85% reported having a tobacco control act,
Financial resources Total AFR AMR EMR EUR SEAR WPRa law, legislation or ministerial decree. Since 2000-2001, for the 118 countries that
Increase tax on cigarette 17 4 26 7 21 17 24 responded to both surveys, there has been a 23% increase in the existence of
these instruments and almost double the number of countries with tobacco control
Increase tax on alcohol 11 4 15 0 18 17 10
action plans, now standing at 65%. Again excluding WPR, 65% of respondents are
Increase tax on unhealthy 1 4 0 0 0 0 0 contracting parties to the FCTC, and 31% report a corresponding comprehensive
imported food action plan. The extent to which there is overlap in the two sections of the survey
International financial 32 31 33 27 16 33 62 asking about tobacco action plans is not known, nor is the nature of the legislation
aids reported, nor the stage reached by any action plan.
Fund raising activities 17 15 11 13 24 0 19 Between 2000 and 2005, 82% of respondents (WPR excluded) said that
Donations from health 18 15 22 13 21 0 19 populations were surveyed for tobacco use while 41% (WPR inclusive) reported
interested private routine surveillance. The surveys could have been at national or sub-national
groups levels. Smoking cessation guidelines are said to be available in one-third of
Unspecific resources 39 31 52 33 45 0 NA countries.
of financial budget
Dedicated budgets for tobacco control were reported in 50% of countries and
Others 24 19 22 20 26 50 NA 17% on average said that cigarette tax is contributing to financing NCD prevention
NA, no data available and control initiatives. For the latter, the proportions were highest in AMR (26%),
a
WPR data were collected in 2004.. WPR (24%) and EUR (21%).
38 39
4. QUALITATIVE RESULTS Table 21 Ranking of chronic non-communicable disease prevention and control as a
priority for action
Key informants in 26 countries participated in interviews. They were located
in low, lower-middle and upper-middle income countries, in all regions except Rank Key informants
EUR, as shown in Table 20.
High 15
Medium 11
Table 20 Key Informant Countries in 2005~2006 Survey Low 0
Region Countries Where a medium rank was assigned, key informants explained that a
AFR Namibia, Uganda, Nigeria government may assign a high priority to the NCD issue in terms of intent, but
AMR Brazil, Chile, Trinidad and Tobago, the priority in reality – in terms of response to NCD – is medium. Health system
funds are largely consumed by necessary treatment and care services. In some
Mexico
cases, the double burden of disease is constraining an effective approach to prevent
EMR Bahrain, Egypt, Jordan, Lebanon, Oman, Syrian
and control NCD. Such policies may be in place but key informants expressed
Arab Republic, Sudan
concerns about implementation, and said that policies are not comprehensive of
SEAR India, Thailand
all the issues they are to address, and lack the instruments to be effective. Some
WPR Cambodia, Fiji, Micronesia, Mongolia, Philippines, WHO-assisted biennial health plans do not identify NCD as a priority. Health
Samoa, Solomon, Tonga, Vanuatu, Viet Nam promotion in general is a high priority and preventing NCD falls under that
initiative. For some countries, advocates for NCD prevention feel that they have
to “compete” with the communicable diseases issue which has a high priority,
There were slight variations in the topics explored in each region to
particularly among rural and peasant populations. High risk of NCD disease is
accommodate the specific information needs of the NCD regional advisors. All seen to reside within middle-class and wealthy populations, who are better able
the interviews delivered information about the following core topics: to access (and are expected to access) health care systems once they are affected.
1) The priority assigned to NCD prevention and control. Mentioned also are situations where a country may have a number of separate
2) The major barriers and constraints to the development and implementation conditions or risk factor strategies in place and ongoing. For example to prevent
of policies and programmes for NCD prevention and control. cancer and diabetes, and to deal with risk factors such as tobacco. But overall,
NCD is not given a high priority, despite data on high mortality and morbidity
3) The nature and extent of surveillance of major chronic diseases and risk
rates. The public and governments are alarmed by NCD rates but mortality data
factor exposure.
are proving to be insufficient to mobilize government spending decisions. There
4) The priority areas for WHO technical support. remains a big gap between the awareness of the NCD problem and the government
decision to respond.
4.1 Ranking of NCD Prevention and Control as a Priority for Action
Key informants also noted that there is uncertainty as to how best to
Table 21 shows that 15 key informants ranked NCD prevention and control take action. NCD prevention and control is a complex issue, and health care
as a high priority in their countries while 11 considered it a medium priority. infrastructures are not being developed to respond with prevention, in some cases
Where it was a high priority, key informants spoke of strong governmental being of relatively small scale to begin with. Planning and finance ministries in
commitment. Recent evidence of the NCD burden such as rising injury rates, government argue a need to hold back the allocation or reallocation of scarce
the high prevalence of diabetes mellitus and cardiovascular diseases, and recent funds on the basis of a lack of evidence on what policies are working in which
public media reports was identified as having contributed to governments placing situations. Some opponents even argue that preventing NCD is an individual’s
high priority on NCD policy development. responsibility and not a population-level issue.
42 43
The continuing influence of the tobacco industry on government decisions was capacity within some primary care services for health professionals to absorb
also mentioned. Policies and action plans that are in place do not comprehensively new activities to deal with risk factors and generally with NCD prevention, both
control tobacco; thus, pricing policy keeps cigarettes still affordable to low-income in terms of their time and the availability of health system funds to compensate
earners among whom high smoking rates prevail. them for their interventions.
4.2 Barriers and Constraints Knowledge/skills/tools as a barrier was related also to the capacity and
competencies of two bodies of people – the front-line of health professionals,
Key informants ranked a list of barriers and constraints, shown in Table 22.
with reference to their training to provide interventions in their respective settings
The lack of financial resources or their total lack was the number one barrier
that prevent and control NCD; and the health policy-makers. For the latter group,
to NCD prevention policy implementation in twelve (12) instances, and human
resources were the top barrier in seven (7). Information systems and public key informants characterized the knowledge barrier as related to the design of
health policy were the next most often cited barriers, followed by health care new policies or strategies that serve to coordinate existing disease- and risk
infrastructure, and finally knowledge/skills/tools. Essential drugs and equipment factor-specific initiatives, and at the same time to join up the actions of health and
were not among the top barriers or constraints to NCD action. non-health government departments. The difficulty of shifting the government’s
perspective from a vertical orientation of strategies to horizontal collaboration
was acknowledged.
Table 22 Key Informant Ranking of Barriers and Constraints
Key informants characterized health information systems as being typically
limited to being institution-based, with hospitals and other treatment centres being
Barriers and Constraints Total that Assigned First Priority the source of NCD mortality data and sometimes morbidity data. Key informants
financial resources 12 also indicated a knowledge gap on the part of public health professionals as to
how to use data most effectively to persuade more government action to prevent
human resources 7
and control NCD.
information systems 5
Also raised was the issue of how to translate the intentions of national policy
public health policy 5
into action at the local levels, where the responsibilities and infrastructures for
health care infrastructure 1 policy implementation, such as they are, are often located. In some cases, local
knowledge/skills/tools 1 structures with health and social services mandates that are currently providing
essential drugs and equipment 0 services have not been certain how to proceed. They understand that taking an
integrated approach calls, for example, for increasing and diversifying local
coalitions and partners and engaging new sectors, but how to start and who is to
In the interviews, key informants linked the lack of financial resources to play what role is not clear.
implement NCD prevention and control interventions to a number of circumstances.
Many were mentioned in section 4.1 above in the explanations of why NCD
4.3 Surveillance of Chronic Disease Prevention and Control and
prevention is not given high priority by governments. To these were added the Risk Factors
lack of awareness by the general public of NCD rates in terms of mortality and Eleven key informants mentioned an active survey of conditions and risk
morbidity, and the lack of knowledge that the risk factors underlying major NCD factors in their countries, including hypertension, diabetes and mental disorders,
are modifiable. There is little “room” in the public’s attention for NCD prevention and diet, weight, alcohol use, tobacco use and physical activity. Most NCD and
given the high profile in the media of such communicable disease concerns as risk factor surveys have been conducted since 2002, some at national levels, others
HIV and bird flu, and of access to health care services. Key informants recognize in regions. Seven key informants mentioned that the WHO STEPwise approach to
that the potential advocacy of the public is missing, a factor that contributes to the chronic disease risk factor surveillance, or a modified approach, is being applied
relatively low levels of funding that governments are willing to allocate to NCD or that preparations are underway, for example the training of interviewers. The
prevention. lowest income countries in the sample reported no NCD or risk factor surveys. In
Human resources as a constraint to NCD intervention were related to health one case, a shortfall of US $65,000 was said to be holding back application of the
care infrastructure. Key informants said that there is limited or non-existent STEPwise approach.
44 45
4.4 Priority Areas of WHO Technical Support for Chronic Disease Also mentioned was assistance with the reorientation and training of health
Prevention and Control promotion and disease prevention professionals to deal with NCDs, since their
traditional emphasis has been on communicable diseases.
Key informants assigned first priority for WHO assistance most often to the
area of policy, action plan and programme development. WHO help with disease
surveillance and training were the next highest priorities.
eliminate NCD risk factors at the population level. Furthermore, WHO can create Even with more countries reporting the existence of protocols for dealing
more instruments similar to FCTC to deal with diet, physical activity and other with risk factors and disease management since 2000-2001, key informants
major risk factors, so as to support and leverage country efforts in implementing continue to ask for assistance in assessing their feasibility and appropriateness for
DPAS and other strategies that are emerging. their local contexts and capacities, and then in training primary care professionals
A top priority for technical assistance from WHO continues to be policy, to use them.
action plan and programme development. An interpretation of what might appear Technical assistance and training are also needed with regard to preparing
as a contradiction – the request for assistance with NCD prevention-related policy information that will be strategic in capturing the attention of policy makers.
while countries have actually made progress in this regard – is that the nature of WHO can assist public health professionals to frame the NCD burden in, for
the assistance with policies and plans has to do with their implementation and how example, economic and sustainable human development terms, using the research
to better design policies to make them more effective. WHO can help with policy and methods that have been developed since 2000-2001. WHO can also give more
development by training policy makers while advocating policy formulation support to training and dissemination of health impact assessment methods among
processes that define key aspects of implementation necessary for a policy to public health professionals, enabling them to point out the potential population
“have legs” from the outset. For example, specifying within an NCD prevention health effects of policies being proposed by non-health sectors and making them
policy declaration the sources and amounts of resources to be available, along with better advocates for healthy public policies.
identifying the general structures and mechanisms through which interventions With regard to the sources of financing for NCD prevention and control,
are to be delivered, would greatly improve the chances that the results intended by about 32% of countries on average identified international financial aid. The
policies, plans and programmes will indeed be realized. Where several initiatives proportion in EUR was lowest (16%). Very few countries reported taxation on
are in place, key informants also indicated a need for assistance in determining tobacco, alcohol and unhealthy food as sources of funding. As for taxes on alcohol,
how to coordinate or join up efforts in order to bring about a degree of integration the countries in EUR have the highest proportions (18%); while the countries in
specific to their political, social and economic realities. AMR have the highest proportions of taxation on cigarettes (26%).
An area for WHO assistance that emerged was that WHO should create While progress is apparent in the countries that responded to both surveys,
more channels, platforms and other occasions for dialogue among Member States a number of key areas still call for action, and these are similar to those that were
to encourage them to be outward looking, to exchange their experiences with reported in 2000-2001. These key areas also re-emerge as priorities for WHO
NCD prevention and control policies, plans, programmes and protocols in an technical support to Member States. They can be summarized as:
environment with peers, to review what is being done and to consider options – Advocacy, with a continuing need for WHO to persuade the general
on how to move forward. WHO can also compile and disseminate examples of public, governments and donor agencies to mobilize sufficient resources
what is being done. Given the diversity of country situations and contexts for for NCD prevention;
NCD prevention, and the huge range in country capacities to respond, WHO can
encourage research to deliver case studies that profile leadership in applying good – Member States still require assistance in strengthening their surveillance
practices relevant to countries by income group. The demonstration programmes systems;
identified in the current survey are potential case studies, as are FCTC and DPAS – Strengthening capacity in developing, implementing and evaluating
action plans. national policies, action plans and programmes for chronic disease
The number of countries reporting risk factor surveys and surveillance has prevention and control;
increased since 2000-2001 but the frequency is not known. Collecting reliable data – Creating more channels, platforms and other occasions for dialogue at
on the major risk factors on a regular basis needs emphasis and support to produce global and regional level and among Member States.
the trends that can inform policy and action plan development and evaluation and, Finally, regular global reviews should be encouraged, not only to help WHO
above all, can support advocacy. Key informants indicate that WHO technical to measure the progress made but also to identify the Member States’ needs for
assistance continues to be needed for training and evaluation of surveillance technical support.
and survey systems for NCD risk factors, disease prevalence and cause-specific
mortality. WHO can also encourage, assist with and profile research on the
relationship between risk factor exposure and NCD prevalence and socioeconomic
determinants, thus broadening the adoption of the equity agenda.
48 49
REFERENCES ANNEX 1
1. WHA51.18. A Global Strategy for the Prevention and Control of
Noncommunicable Diseases. Resolution of the 51st World Health Assembly.
GLOBAL SURVEY QUESTIONNAIRE
Geneva, World Health Organization, 20 May 1998.
2. WHA53.17. Prevention and Control of Noncommunicable Diseases. National Chronic Diseases Prevention and Control Questionnaire
Report of the Director General. 53rd World Health Assembly. Geneva, World
Health Organization, 20 May 1998. Thank you for agreeing to complete this questionnaire. We really appreciate
3. The World Health Report 2002: Reducing risks, promoting healthy life. your efforts.
Geneva, World Health Organization, October 2002. The objectives of the WHO global survey are to assess the capacity of national
4. WHO Framework Convention on Tobacco Control. Geneva, World chronic disease prevention and control in development, and implementation
Health Organization, May 2003. of national policy, and action plan and programmes, to promote sharing of
information, experiences and best practices, to identify constraints and needs and
5. WHA51.17. Global Strategy on Diet, Physical Activity and Health.
to assist national strategy and policy formulation, development, implementation
Geneva. May 22, 2004. Resolution of the 57th World Health Assembly. Geneva,
and evaluation of programmes.
World Health Organization, 20 May 1998.
The last WHO global survey to assess national capacity for chronic diseases /
6. Preventing chronic diseases: a vital investment. Geneva, World Health
NCD prevention and control was carried out in 2001. Those results are available
Organization, October 2005.
from: http://whqlibdoc.who.int/hq/2001/WHO_MNC_01.2.pdf. The results from
7. Alwan A, Maclean D, Mandil A. Assessment of national capacity for the analysis of this 2005 survey will be made available through the WHO website
noncommunicable disease prevention and control: the report of a global survey. with links to relevant policy documents for each country, where these exist. To
Geneva, World Health Organization, 2001. enhance quality of data collection, some countries may be contacted for further
8. Microsoft Corporation. Microsoft Excel 2003. Redmond, Washington: information on receipt of questionnaire.
Microsoft Corporation, 2003.
COUNTRY NAME: _________________________________________________
9. Centers for Disease Control and Prevention. Epi Info: version 6.04d.
This is a current profile of the chronic disease prevention and control in this
Atlanta, Georgia: Centers for Disease Control and Prevention, 2001.
country/territory.
10. Stata Corporation. Stata statistical software: release 9.0. College Station, We understand that it will be used in a global analytic report.
Texas: Stata Corporation, 2005.
NAME OF PRINCIPAL PERSON FILLING IN THE QUESTIONNAIRE:
Surname: _____________________ First Name: _____________________
DESIGNATION /TITLE: __________________________________________
SIGNATURE: ______________________
DATE OF COMPLETION: ** 14-Aug-07 (dd/mm/yyyy)
50 51
Note: A3 Are there national institutes for public health or chronic disease
1. This questionnaire is accompanied by two documents to assist you in prevention and control – or equivalent (Other)?
completing the questionnaire: the Preamble which explains the background Yes ® No ® Other ®
to this survey, and the Objectives, Terms and Definitions.
If Yes, please provide us with the name and website of the institute, where
2. If you have any difficulty or need to discuss this in any way, please contact this exists:
WHO Regional Office for**********; Dr *******, WHO/***** at
***@****** for ***** Region;
B. National Act, Law, Legislation, Ministerial Decree for Chronic Diseases
3. We prefer that you complete the questionnaire in an electronic version.
Prevention and Control
Further copies of the form are available at from your Regional counterpart,
the WHO Headquarters focal point ([email protected]) or the WHO website These are nationally approved act, law, legislation or ministerial decree for
(http://www.who.int). prevention and control of chronic diseases.
4. Some of the questions require that you provide supplementary material
B1 Does your country have Tick box, Type Year, Title and website
(e.g. documents, reports and published papers). We would prefer to receive
an act, law, legislation, if yes (or PDF file), if exists
an electronic copy of each (WORD, PDF etc) and the website where the
ministerial decrees
document is located. If electronic version is unavailable, please send
developed on the
two hard (paper) copies of each. If the original document is in another following areas
language, we would be grateful to receive a short abstract in English.
a. Tobacco control ** ®
5. We recommend that you discuss this questionnaire with the relevant
®
people or focal points at the national level prior to completion to ensure
as full a response as possible. ®
b. Food and nutrition ®
A. National Focal Point, Unit/department, and Institute • Specific food product ®
e.g. fat consumption,
A1 Is/are there a focal point(s) for overall prevention and control of chronic salt control
diseases in the Ministry of Health and /or in your Organization?
• Settings: school, ®
Yes ® No ® workplace
If yes, please give contact details of lead person as follows: c. Alcohol control ** ®
Surname: .................................... First Name: .......................................... d. Physical activity ®
Designation /Title: ...................... Unit /Department: ................................ e. Any other regulatory ®
instruments of
Address: ........................................................................................................ relevance to Chronic
Tel: .............................................. Fax: ...................................................... disease prevention
Email: ............................................................................................................ and control? (please
indicate)
A2 Is there a unit (or department) for prevention and control of chronic
Any other comments you wish to add regarding section B?: .........................
diseases in the Ministry of Health?
.................................................................................................................................
Yes ® No ® .................................................................................................................................
If Yes, what is the total Number of staff: .................................................................................................................................
52 53
C. Policy, Strategy, Action Plan, Programme C4 Does your country have If yes, Year, Title (original and English)
individual national please and website (or PDF file), if exists
These are nationally approved policies, strategies, action plans, programmes for
policies developed on tick
the prevention and control of chronic diseases.
the following areas
.
a. Tobacco Control ®
C1 Does your country have a national health policy relevant to chronic
diseases prevention and control? b. Nutrition/diet ®
Yes ® No ® c. Physical Activity ®
If yes, please give: Effective Year: ........ Title (original and English): .... d. Alcohol Control ®
....................................website (or PDF file), if exists: ............................. e. Hypertension ®
Please provide hard (paper) copy, if electronic version does not exist. f. Diabetes ®
C2 Does your country have a national health strategy relevant to g. Heart Diseases ®
prevention and control of chronic diseases? h. Stroke ®
Yes ® No ® i. Cancer ®
If yes, please give: Effective Year: ........ Title (original and English): .... j. Chronic respiratory ®
....................................website (or PDF file), if exists: ............................. disease
Please provide hard (paper) copy, if electronic version does not exist. k. Other chronic disease/ ®
C3 Does your country have national integrated programmes for chronic NCD of importance in
diseases prevention and control which cover all or some of the your country
major risk factors (tobacco use, nutrition, physical inactivity, alcohol C5 Does your country have If yes, Year, Title (original and English)
consumption), or main chronic diseases (heart diseases, stroke, cancer, individual national please and website (or PDF file), if exists
chronic respiratory diseases, hypertension, diabetes)? action plans developed on tick
Yes ® No ® the following areas
If yes, please give details: a. Tobacco Control ®
Effective Year: ....... Title (original and English): .................................. b. Nutrition/diet ®
...............................website (or PDF file), if exists: .................................. c. Physical Activity ®
Please provide hard (paper) copy, if electronic version does not exist. d. Alcohol Control ®
e. Hypertension ®
f. Diabetes ®
g. Heart Diseases ®
h. Stroke ®
i. Cancer ®
j. Chronic respiratory ®
disease
k. Other chronic disease/ ®
NCD of importance in
your country
54 55
C6 Does your country have If yes, Year, Title (original and English) D2 Which organizations were involved in setting population targets for
individual national please and website (or PDF file), if exists chronic disease prevention and control? (Please tick)
programmes developed on tick Ministry of Health ® Associations for ®
the following areas specific population
a. Tobacco Control ® groups e.g. Men’s,
b. Nutrition/diet ® Women’s or Youth
Organizations
c. Physical Activity ®
Ministry of Education ® Consumer ®
d. Alcohol Control ® Organizations
e. Hypertension ® Ministry of Finance ® Medical /Health ®
f. Diabetes ® professional
g. Heart Diseases ® Associations
h. Stroke ® Other Ministries (Specify) ® Disease-specific ®
Associations e.g.
i. Cancer ® Cancer Society,
j. Chronic respiratory ® Diabetes Associations
disease Subnational Government ® International ®
k. Other chronic disease/ ® Nongovernmental
NCD of importance in Organizations
your country World Health Organization ® Other Bilateral/ ®
C7. Are there any relevant policies / plans in preparation? multilateral
Organizations
Yes ® No ®
If yes, please give details ............................................................................... National nongovernmental ® Academic institutions ®
Organizations
Any other comments you wish to add regarding section C?: .........................
Citizen or community ® Others (please ®
.................................................................................................................................
representatives specify)
.................................................................................................................................
Any other comments you wish to add regarding section C?: .........................
D. National Target .................................................................................................................................
D1 Please complete the table below on the areas of chronic disease or E. Implementation of the Framework Convention on Tobacco Control
major risk factors where National targets for prevention and control (FCTC) and the Global Strategy on Diet, Physical activity and Health(DPAS)
have been set.
E1. Has your country become a contracting Party to the WHO FCTC?
Area/aspect of chronic diseases (or National targets
Yes ® No ®
risk factors, health determinants)
If Yes, does your country have an action plan for the implementation of the FCT,
in addition to any Tobacco Control action plan already mentioned in section C?
Yes ® No ®
If Yes, please provide us with a copy of the document or Web site and
electronic file (in word, PDF).
56 57
E2. Are there aspects of FCTC implementation you need assistance with F2 During the past 5 years (2000-2005), were national/provincial studies/
from WHO? surveys carried out on: (Please tick)
Yes ® No ®
Tobacco use ® Raised blood glucose ®
E3. Does your country implement the DPAS?
Yes ® No ® Unhealthy diet ® Raised blood pressure ®
If Not, Does your country have plans for the implementation of the DPAS? Physical inactivity ® Dyslipidaemia ®
Alcohol consumption ® Heart diseases ®
Yes ® No ®
Hypertension ® Stroke ®
If Yes, please provide us with links to the website where the plans is the and
the electronic copy (word, PDF, etc), or provide us with a hard copy. Diabetes ® Cancer ®
E4. Does your country have a mechanism in place for discussion/interaction Overweight and obesity ® Chronic respiratory diseases ®
between national authorities and private sector interests related to the F3 Does your country have a routine or regular surveillance system for
DPAS? chronic diseases/risk factors?
Yes ® No ® Yes ® No ®
If yes, what is the mechanism? If Yes, please state:
E5. Are there aspects of DPAS implementation you need assistance with • the year initiated date last completed:
from WHO? • the periodicity age groups covered:
Yes ® No ® and provide us with a Web site and electronic file (in word, PDF)of the
most recent report
F. National health reporting system, survey and surveillance F4 Which of the following chronic diseases/risk factors does your
country’s chronic disease surveillance system cover? (Please tick)
National health reporting system refers to annual or regular health report Tobacco use ® Overweight and obesity (Body ®
system of MOH; Survey refers to regular, fixed or unfixed time interval national Mass Index)
health survey; Surveillance refers to the ongoing monitoring and reporting/
analysis of chronic disease/risk factors, morbidity and mortality due to chronic Unhealthy diet e.g. ® Dyslipidaemia (cholesterol) ®
disease in a population. low fruit and vegetable
intake
F1 a. Does your country have a health information system in which chronic Physical inactivity ® Heart diseases ®
disease and major risk factors are part of system? Alcohol consumption ® Stroke ®
Yes ® No ® If yes,
Diabetes (Elevated ® Cancer ®
b. Are chronic diseases included in the annual health report system? blood glucose)
Yes ® No ® If yes,
Hypertension (Elevated ® Chronic respiratory diseases ®
c. Please specify the data included: blood pressure)
1) Risk factors ® 2) Cause-specific mortality ® 3) Morbidity ®
F5. Has the WHO Stepwise approach to surveillance for risk factors been
d. How are the results made available e.g. website?
implemented in your country?
e. How has the information been used for decision-making or policy- Yes ® No ®
making?
Any other comments you wish to add regarding section F?: .........................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
58 59
G. National community-based demonstration programme for chronic G4 Does your country have health promotion and chronic Yes No
disease prevention and/or health promotion disease prevention and control demonstration project(s) for
individual settings?
Refers to national demonstration community-based chronic disease prevention (Please tick all that apply).
and control and/or health promotion programmes targeting major risk factors, group
of population or settings. Please provide a website and electronic evaluation report, if
these exist?
G1 Does your country have health promotion and chronic Yes No Workplace ® ®
disease prevention and control demonstration site(s) for ® ® School ® ®
integrated chronic disease prevention and control?
Hospital and clinics ® ®
If yes, what?
Community ® ®
Please provide a website and electronic evaluation report, if
these exist? Family ® ®
G2 Does your country have health promotion and chronic Yes No Others(please indicate) ® ®
disease prevention and control demonstration site(s) for ® ® Any other comments you wish to add regarding section G?: ........................
tackling individual risk factors? .................................................................................................................................
If yes, what? .................................................................................................................................
.................................................................................................................................
Please provide a website and electronic evaluation report, if
these exist?
G3 Does your country have health promotion and chronic Yes No
disease prevention and control demonstration project(s) for
individual population groups?
(Please tick all that apply).
Please provide a website and electronic evaluation report, if
these exist?
Children 15 years and Under ® ®
Young People and Adolescents, 15 –24 years ® ®
Adults, 25 – 64 years ® ®
Elderly, 65 years and over ® ®
Women ® ®
Others (please indicate) ® ®
60 61
Chronic Diseases (Noncommunicable Diseases) 2. National Act, Law, Legislation, Ministerial Decree:
In this questionnaire, the terms “chronic diseases” and “noncommunicable i. Refers to nationally approved acts, laws, legislation, ministerial decrees
diseases” are considered synonymous. This questionnaire primarily focuses on targeting prevention and control of chronic diseases and risk factors; or
four prominent chronic diseases, which are given a high priority by the WHO prevention and control of chronic diseases or related risk factors as part of
Global Strategy for Noncommunicable Diseases Prevention and Control. legislations concerned.
These four diseases are, cardiovascular diseases, cancer, diabetes, and chronic ii. Tobacco legislation: This deals with legal provisions for tobacco control
respiratory diseases. Cardiovascular disease include heart disease and stroke including information on health hazards from different tobacco products,
(cerebrovascular accidents); cancer includes malignant tumors of organs such as passive smoking, protection of children, and different laws for tobacco
brain, lung, prostate, breast but also leukaemias and lymphomas; diabetes refers prevention, cessation, taxation, and distribution of tax revenues.
to diabetes mellitus; and chronic respiratory diseases includes chronic obstructive
pulmonary disease (COPD) and asthma. iii. Food and nutrition legislation: Deals with legal provisions for food and
nutrition, including manufacturing, labelling, quality assurance standards,
Chronic Disease Prevention and Control (CDPC) food protection regulation, etc. In this questionnaire, the food and/or
For the purpose of this questionnaire, CDPC includes all activities related to sur- nutrition legislation is related to chronic diseases prevention and control,
veillance, prevention and management of the four chronic diseases mentioned above. or chronic diseases prevention and control is part of its concerns.
ii. Policy: In the context of the Chronic Disease Prevention and Control, 5. National health reporting system, survey and surveillance:
policy means consensus among relevant partners on issues to be addressed i Annual health reporting system: This includes the annual health reports
and on approaches or strategies to be used in doing so. Therefore, a of the MOH, containing data on national capacity, human resources,
national policy for chronic disease prevention and control refers to a demographic data, health expenditure, health indicators. Morbidity
written document endorsed, in collaboration with related sectors, by the information many include incidence or prevalence data from disease
country’s Ministry of Health (MOH), which includes a set of statements registries, hospital admission or discharge data.
and decisions defining goals, priorities and main directions for attaining
these goals. The policy document may also include a strategy containing ii National survey: Refers to national fixed or unfixed time interval survey
main lines of action that are adopted to give effect to the policy. on the main chronic diseases, or major risk factors common to chronic
diseases.
iii. National integrated action plan (NIAP): Refers to the countries
iii Surveillance: Refers to information on risk factors, chronic diseases
core public health principles incorporated into country action plan for
and their determinants, which is a continuous analysis, interpretation
chronic diseases prevention and control through a concerted approach to
and feed-back of systematically-collected data using survey or regular
addressing the multidisciplinary range of issues within a prevention and
registration.
health promotion framework across the broad range of chronic diseases.
NIAP targets all major common risk factors common to main chronic 6. National community-based demonstration programmes for chronic
diseases, and integrate primary, secondary and tertiary prevention, health disease prevention and/or health promotion:
promotion and diseases prevention, and programmes across sectors and
Refers to national community-based demonstration programmes that address
disciplines through, rather than rely on, a disjointed set of small scale
issues relevant to chronic disease prevention and major risk factors; apply
projects through a set of actions, harmonizing actions, integrating actions
existing knowledge to practice effective prevention at community level;
with existing public health systems by incorporating contemporary
examine different methods of disease prevention and health promotion;
evidence-based concepts into this approach.
evaluate their feasibility; and validate their effect and how they can be a
iv. National action plan: This is a scheme, prepared according to policy and source of public and professional inspiration. Large or national programmes
strategic directions, and defining activities, to generate products/targets based on experience of the demonstration areas can be launched.
set to achieve the desired goals. The plan should identify who does what
(type of activities and people responsible for implementation), when 7. Implementation of FCTC and DPAS:
(time frame), how and for how much (resource). It should ideally have an Refers to the national action plan or work plan for implementation of the
inherent mechanism for monitoring and evaluation. Framework Convention on Tobacco Control (FCTC) adopted by WHA 56
v. National programmes: Refers to the understanding of the national in May 2003, and the Global Strategy for Diet, Physical Activity and Health
overall goal and objectives within the framework of national chronic (DPAS) endorsed by WHA 57 in May 2004.
disease prevention and control, translate these into programme goals and
8. National Protocols/Guidelines/Standards for Chronic Diseases and
objectives that are consistent with the intervention strategies and from
Conditions:
these develop a blueprint of how the intervention activities will operate
and evaluate the results. Refers to prevention, treatment or management services that deal with an
already existing chronic disease or risk factors aiming to treat and control
vi. Capacity: The ability to perform appropriate tasks effectively, efficiently
the condition, prevent complications, improve outcomes and quality of life
and sustainably (at national level) of patients.
4. National Target: 9. Financial Resources:
Refers to setting of quantitative output, impact, outcomes or health indicators Refers to specific chronic disease prevention or risk factors intervention
for chronic diseases prevention and control (or risk factors such as tobacco and budget allocation for prevention and control in any of the chronic
use, unhealthy diet and physical inactivity, and health determinants such as diseases components and the source of financial support for chronic diseases
environment, lifestyles, socio-economics etc). prevention and control.
66 67
ANNEX 3 4. In the survey mentioned above, your country indicated that it had national
programmes/projects in the area of chronic diseases prevention and control.
In a few words could you describe the nature and extent of these programmes/
KEY INFORMANT QUESTIONS projects?
Interviewer comments:
Interview Questions Regarding Chronic Diseases Prevention and 5. In the survey mentioned above, your country indicated that there was
Control for Key Informants legislation in place regarding tobacco control and food and nutrition. In a
few words could you describe the nature and extent of this legislation?
Date:
Member State:
Tobacco:
Key Informant:
Food and Nutrition:
1. How would you rank NCD prevention and control as a priority for action
Interviewer comments:
given the present health status of your country’s population and the capacity
of your health system? 6. In the survey mentioned above, your country indicated that there was a
surveillance system (or register) for chronic diseases. In a few words could
low median high
you indicate the nature and extent of this system?
Interviewer comments: Chronic diseases Population-based Institution-based
2. What do you think are the major constraints or barriers (top 3) to the develop- Hypertension
ment and implementation of policies and programmes for chronic diseases
Diabetes
prevention and control in your country? (rank in order all that apply).
Heart diseases
a) Public health policy
Stroke
b) Fiscal resources
Cancer
c) Human resources Chronic respiratory diseases
d) Information systems
e) Health care infrastructure Interviewer comments:
f) Essential drugs and equipment 7. In the survey mentioned above, your country indicated that there was a
g) Knowledge/skills/tools surveillance system that included surveillance for some of the chronic
diseases risk factors namely ……………… . In a few words please indicate
h) Other
the nature and extent of these systems?
Interviewer comments:
3. In the survey conducted in 2005 by WHO entitled “ The Global Survey on Risk factors Population-based Institution-based
Progress of National Chronic Disease Prevention and Control “, your country Tobacco use
indicated that it had an official policy or plans in the area of chronic diseases
Unhealthy diet
prevention and control. In a few words could you describe the nature and
extent of the policy or plans or programmes? Physical inactivity
Interviewer comments:
8. In the survey mentioned above, your country indicated that there were chronic AFRICAN REGION Zimbabwe
disease prevention and control programmes integrated with the primary Angola
health care system. In a few words could you describe the nature of these
programmes and explain what the term “integrated” means in this context? Benin REGION OF THE
Cameroon AMERICAS
Interviewer comments: Cape Verde Antigua and Barbuda
9. Implementation of the WHO Global Strategy on Diet, Physical Activity and Congo Argentina
Health (DPAS): Bahamas
Côte d’Ivoire
1) In the survey mentioned above, your country defined the mechanism in Barbados
place for discussion/interaction between national authorities and private Democratic Republic of the
sector interests related to the DPAS. In a few words could you please Congo Belize
indicate the nature and extent of this mechanism? Eritrea Bolivia
2) Are there aspects of DPAS implementation for which you need assistance Ethiopia Brazil
from WHO?
Gabon Chile
10. What do you think should be the major priority areas for WHO technical
Ghana Colombia
support for chronic diseases prevention and control for your country? (Rank
in order all that apply). Kenya Costa Rica
a) Training for human resource development Madagascar Cuba
b) Establishing demonstration programmes Malawi Dominican Republic
c) Policy, action plans and programmes development for chronic diseases Mali Ecuador
prevention and control Mauritania El Salvador
d) Assistance with chronic diseases surveillance Mauritius Guatemala
e) Assistance with risk factor surveillance Namibia Guyana
f) International collaboration and networking Niger Haiti
g) Other Sao Tome and Principe Jamaica